These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 9072703
21. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. Bruera E, Palmer JL, Bosnjak S, Rico MA, Moyano J, Sweeney C, Strasser F, Willey J, Bertolino M, Mathias C, Spruyt O, Fisch MJ. J Clin Oncol; 2004 Jan 01; 22(1):185-92. PubMed ID: 14701781 [Abstract] [Full Text] [Related]
22. Switching from methadone to tapentadol for cancer pain. Mercadante S, Ferrera P, Adile C. J Pain Symptom Manage; 2012 Sep 01; 44(3):e3-5. PubMed ID: 22819437 [No Abstract] [Full Text] [Related]
23. Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: a pilot study. Fisher K, Stiles C, Hagen NA. J Pain Symptom Manage; 2004 Dec 01; 28(6):619-25. PubMed ID: 15589088 [Abstract] [Full Text] [Related]
26. [Cancer-related pain]. Lundorff LE, Eriksen J, Sjøgren P. Ugeskr Laeger; 2006 May 15; 168(20):1960-2. PubMed ID: 16768893 [Abstract] [Full Text] [Related]
27. [Fentanyl by buccal administration. Fifty to hundred times stronger than morphine against pain]. Taeron C. Rev Infirm; 2002 Sep 15; (83):47-9. PubMed ID: 12380268 [No Abstract] [Full Text] [Related]
30. Methadone in cancer pain management: individualize dose and titrate to effect. Foley KM, Houde RW. J Clin Oncol; 1998 Oct 15; 16(10):3213-5. PubMed ID: 9779693 [No Abstract] [Full Text] [Related]
31. Rapid switching between transdermal fentanyl and methadone in cancer patients. Mercadante S, Ferrera P, Villari P, Casuccio A. J Clin Oncol; 2005 Aug 01; 23(22):5229-34. PubMed ID: 16051965 [Abstract] [Full Text] [Related]
32. Opioid switch to oral methadone in cancer pain. Mancini I, Lossignol DA, Body JJ. Curr Opin Oncol; 2000 Jul 01; 12(4):308-13. PubMed ID: 10888415 [Abstract] [Full Text] [Related]
33. Low morphine doses in opioid-naive cancer patients with pain. Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Ficorella C, Verna L, Tirelli W, Villari P, Arcuri E. J Pain Symptom Manage; 2006 Mar 01; 31(3):242-7. PubMed ID: 16563318 [Abstract] [Full Text] [Related]
34. Getting comfortable with methadone. J Support Oncol; 2003 Mar 01; 1(1):52. PubMed ID: 15352643 [No Abstract] [Full Text] [Related]
35. [Morphine and methadone in severe cancer pain--new pharmacokinetic bases for optimal therapy]. Lööf G, Paalzow L, Jaspersen HP. Pharm Acta Helv; 1983 Mar 01; 58(7):189-95. PubMed ID: 6889408 [No Abstract] [Full Text] [Related]
36. Pharmaceutics: choice of a strong analgesic for cancer patients. Reich SD. Cancer Nurs; 1982 Feb 01; 5(1):67-9. PubMed ID: 6121621 [No Abstract] [Full Text] [Related]
37. Morphine in intrasite gel applied topically to painful ulcers. Zeppetella G, Ribeiro MD. J Pain Symptom Manage; 2005 Feb 01; 29(2):118-9. PubMed ID: 15733803 [No Abstract] [Full Text] [Related]
38. [Nociceptive cancer pain in adult patients: statement about guidelines related to the use of antinociceptive medicine]. Binhas M, Krakowski I, Marty J. Ann Fr Anesth Reanim; 2007 Jun 01; 26(6):502-15. PubMed ID: 17560755 [Abstract] [Full Text] [Related]
39. Switching to methadone: 'ad libitum' or fixed dose ratio? Mercadante S. Palliat Med; 2004 Jan 01; 18(1):71; author reply 72. PubMed ID: 14982211 [No Abstract] [Full Text] [Related]
40. Drug treatment of cancer pain. Med Lett Drugs Ther; 1982 Oct 29; 24(621):95-6. PubMed ID: 6128666 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]